Anuh Pharma Profile
Key Indicators
- Authorised Capital ₹ 51.00 Cr
as on 05-07-2024
- Paid Up Capital ₹ 25.06 Cr
as on 05-07-2024
- Company Age 64 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 95.03 Cr
as on 05-07-2024
- Satisfied Charges ₹ 112.08 Cr
as on 05-07-2024
- Revenue 8.49%
(FY 2023)
- Profit 18.38%
(FY 2023)
- Ebitda 9.45%
(FY 2023)
- Net Worth 12.84%
(FY 2023)
- Total Assets 16.65%
(FY 2023)
About Anuh Pharma
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 506260.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 51.00 Cr and a paid-up capital of Rs 25.06 Cr.
The company currently has active open charges totaling ₹95.03 Cr. The company has closed loans amounting to ₹112.08 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Anuh Pharma Limited India are Ritesh Shah as Ceo, Darshan Rampariya as Cfo, and Vivek Shah as Ceo. Arun Lalchand, Bipin Shah, Ketan Shah, and Nine other members serve as directors at the Company.
- CIN/LLPIN
L24230MH1960PLC011586
- Company No.
011586
- Stock Symbol
BSE : 506260
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 Feb 1960
- Date of AGM
18 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Anuh Pharma?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ritesh Shah  | Managing Director | 09-Aug-2016 | Current |
| Vivek Shah | Managing Director | 09-Aug-2016 | Current |
| Darshan Rampariya | CFO | 23-May-2014 | Current |
Board Members(10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harmanbhai Patel | Director | 22-May-2019 | Current |
| Gaurav Shah | Director | 01-Jul-2023 | Current |
| Mita Dixit | Director | 08-Feb-2019 | Current |
| Arun Lalchand | Director | 24-Oct-2008 | Current |
| Bipin Shah | Director | 01-Apr-2009 | Current |
| Ketan Shah | Director | 09-Aug-2016 | Current |
Financial Performance and Corporate Structure Insights of Anuh Pharma.
Anuh Pharma Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.49% increase. The company also saw a substantial improvement in profitability, with a 18.38% increase in profit. The company's net worth Soared by an impressive increase of 12.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anuh Pharma?
In 2023, Anuh Pharma had a promoter holding of 70.58% and a public holding of 29.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
S Kant Chemicals Private LimitedActive 30 years 3 monthsBharat Shah, Gaurav Shah and 1 more are mutual person
Eskay Iodine Private LimitedActive 13 years 3 monthsBipin Shah, Ketan Shah and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 02 Feb 2017 | ₹95.00 Cr | Open |
Canara Bank Creation Date: 08 Jan 1987 | ₹0.30 M | Open |
Bank Of India Creation Date: 06 Jan 2007 | ₹65.00 Cr | Satisfied |
How Many Employees Work at Anuh Pharma?
Anuh Pharma has a workforce of 212 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anuh Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anuh Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
